From the Guidelines
Yes, a Primary Care Physician (PCP) can prescribe EluRyng, a vaginal ring containing etonogestrel and ethinyl estradiol, as a contraceptive method. PCPs routinely prescribe various contraceptives, including hormonal options like EluRyng, as part of comprehensive women's healthcare. The EluRyng is a flexible ring inserted into the vagina for three weeks, then removed for one week to allow for a withdrawal bleed before inserting a new ring. It works by releasing hormones that prevent ovulation, thicken cervical mucus to block sperm, and thin the uterine lining to prevent implantation. Before prescribing, the PCP will typically conduct a medical history review and possibly a physical exam to ensure there are no contraindications such as history of blood clots, certain cancers, uncontrolled high blood pressure, or smoking in women over 35. Patients should be informed about proper insertion and removal techniques, the importance of timing, and potential side effects including spotting, headaches, nausea, and breast tenderness. Regular follow-up appointments are recommended to monitor for any adverse effects, as suggested by the most recent guidelines 1. Key considerations include the patient's medical history, reproductive life plan, and potential risk factors for thromboembolic disease, as outlined in the U.S. Selected Practice Recommendations for Contraceptive Use, 2024 1. The effectiveness of EluRyng as a contraceptive method is supported by studies on combined hormonal contraceptives, which have been shown to have a high effectiveness rate when used correctly 1. Overall, the decision to prescribe EluRyng should be based on a thorough evaluation of the patient's individual needs and medical history, with consideration of the latest clinical guidelines and evidence-based recommendations 1.
From the Research
PCP Prescribing Authority
- A Primary Care Physician (PCP) can prescribe various contraceptive methods, including hormonal contraceptives like the etonogestrel-ethinyl estradiol vaginal ring (EluRyng) 2.
Eligibility and Safety
- The etonogestrel-ethinyl estradiol vaginal ring is a contraceptive method that has been associated with an increased risk of venous thrombosis (VT), with a reported risk increase of 6.5 3.
- PCPs should consider the potential risks and benefits of prescribing EluRyng, particularly in patients with a history of blood clots or other risk factors for VT.
Prescribing Considerations
- When prescribing EluRyng, PCPs should inform patients of the potential risks, including the increased risk of VT, and discuss alternative contraceptive methods 3.
- PCPs should also consider the patient's medical history, age, and other factors that may affect the safety and efficacy of EluRyng.